Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rui-Bin Su

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
European Journal of Pharmacology|April 6, 2010
Spinal antinociception of synthetic omega-conotoxin SO-3, a selective N-type neuronal voltage-sensitive calcium channel blocker, and its effects on morphine analgesia in chemical stimulus tests in rodentLing-Di Yan, Yan-Li Liu, Lei Zhang, et al.
World Journal of Gastroenterology|March 30, 2013
Effect of thienorphine on intestinal transit and isolated guinea-pig ileum contractionPei-Lan Zhou, Yu-Lei Li, Ling-Di Yan, et al.
Acta Pharmacologica Sinica|January 19, 2016
Y-QA31, a novel dopamine D3 receptor antagonist, exhibits antipsychotic-like properties in preclinical animal models of schizophreniaXue Sun, Hong-yan Gou, Fei Li, et al.
Addiction Biology|April 22, 2011
YQA14: a novel dopamine D3 receptor antagonist that inhibits cocaine self-administration in rats and mice, but not in D3 receptor-knockout miceRui Song, Ri-Fang Yang, Ning Wu, et al.
Scientific Reports|November 4, 2015
Antinociceptive effects of incarvillateine, a monoterpene alkaloid from Incarvillea sinensis, and possible involvement of the adenosine systemMei-Liang Wang, Gang Yu, Shou-Pu Yi, et al.
CNS Neuroscience & Therapeutics|November 5, 2013
Generation and primary phenotypes of imidazoline receptor antisera-selected (IRAS) knockout miceLing Zhang, Tai-Yun Zhao, Ning Hou, et al.
Acta Pharmacologica Sinica|May 16, 2017
The opioid receptor triple agonist DPI-125 produces analgesia with less respiratory depression and reduced abuse liabilityShou-Pu Yi, Qing-Hong Kong, Yu-Lei Li, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
European Journal of Pharmacology|April 6, 2010
Spinal antinociception of synthetic omega-conotoxin SO-3, a selective N-type neuronal voltage-sensitive calcium channel blocker, and its effects on morphine analgesia in chemical stimulus tests in rodentLing-Di Yan, Yan-Li Liu, Lei Zhang, et al.
World Journal of Gastroenterology|March 30, 2013
Effect of thienorphine on intestinal transit and isolated guinea-pig ileum contractionPei-Lan Zhou, Yu-Lei Li, Ling-Di Yan, et al.
Acta Pharmacologica Sinica|January 19, 2016
Y-QA31, a novel dopamine D3 receptor antagonist, exhibits antipsychotic-like properties in preclinical animal models of schizophreniaXue Sun, Hong-yan Gou, Fei Li, et al.
Addiction Biology|April 22, 2011
YQA14: a novel dopamine D3 receptor antagonist that inhibits cocaine self-administration in rats and mice, but not in D3 receptor-knockout miceRui Song, Ri-Fang Yang, Ning Wu, et al.
Scientific Reports|November 4, 2015
Antinociceptive effects of incarvillateine, a monoterpene alkaloid from Incarvillea sinensis, and possible involvement of the adenosine systemMei-Liang Wang, Gang Yu, Shou-Pu Yi, et al.
CNS Neuroscience & Therapeutics|November 5, 2013
Generation and primary phenotypes of imidazoline receptor antisera-selected (IRAS) knockout miceLing Zhang, Tai-Yun Zhao, Ning Hou, et al.
Acta Pharmacologica Sinica|May 16, 2017
The opioid receptor triple agonist DPI-125 produces analgesia with less respiratory depression and reduced abuse liabilityShou-Pu Yi, Qing-Hong Kong, Yu-Lei Li, et al.
Pageof 6